Paratek Pharmaceuticals Inc.

Paratek Pharmaceuticals Inc.

Paratek Pharmaceuticals Inc.

Overview
Date Founded

2001

Headquarters

75 Park Plaza, 4th Floor, Boston, MA, 02116, USA

Type of Company

Public

Employees (Worldwide)

41

Industries

Biotechnology
Hospitals & Patient Services

Company Description

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases.

Executives & Employees

Chief Executive Officer

Chief Executive Officer

President & Chief Commercial Officer

Executive Director, Microbiology

Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer

Chief Development & Regulatory Officer

Vice President & Associate General Counsel

Vice President-Controller

Senior Vice President-Business Development

Vice President, Clinical & Medical Affairs

Board of Directors

Former Chief Executive Officer at Paratek Pharmaceuticals Inc.

Adjunct Professor for Strategy & Entrepreneurship at The University of North Carolina, Chapel Hill - Kenan-Flagler Business School

Chief Medical Officer at YourEncore, Inc.

President & Chief Executive Officer at Cidara Therapeutics, Inc.

Managing Member at Codfish Investments LLC

Former Chief Executive Officer at Valeritas, Inc.

Chief Executive Officer at Egalet US, Inc.

Chief Executive Officer at Paratek Pharmaceuticals Inc.

Paths to Paratek Pharmaceuticals Inc.
Potential Connections via
Relationship Science
You
Paratek Pharmaceuticals Inc.
Transaction Advisors
Investment Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Investment Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Legal Advisor

Advised on purchases Paratek Pharmaceuticals, Inc. (Inactive) from Aisling Capital, Omega Funds, HBM Healthcare Investments AG

Advisors & Consultants
Legal Advisor

Partner at Latham & Watkins LLP

Consultant

Chief Financial Officer at KSQ Therapeutics, Inc.

Publicist
Key Stats and Financials As of
Market Capitalization
$141M
Total Enterprise Value
Earnings Per Share
Investors
Details Hidden

Aisling Capital LLC invests in private and small cap publicly traded equities located in the US. The firm targets companies operating in the fields of developing & commercializing important and innovative healthcare products, services & technologies. It provides equity, debt and other structured securities financing for royalty deals, large cap leveraged buyout, seed and venture financing of development stage companies.

Details Hidden

The D. E. Shaw group is a global investment and technology development firm with more than 1,000 employees, approximately $27 billion in investment capital as of October 1, 2012, and offices in North America, Europe, and Asia. Since our founding in 1988, our firm has earned an international reputation for successful investing based on innovation, careful risk management, and the quality and depth of our staff. We have a significant presence in the world's capital markets, investing in a wide range of companies and financial instruments in both developed and developing economies. Our culture demands and rewards analytical rigor and adherence to the highest possible ethical and legal standards, and we've cultivated a collegial work environment that promotes collaboration across disciplines, geographies, and investment strategies. Our firm has been built in part by attempting to do what other companies might consider impossible, or never imagine at all. A single transformative idea that ultimately works—for a new business, a new trading model, or an improved back office process—is worth a dozen ideas that lead nowhere. We've learned that when an extraordinary team sets extraordinarily ambitious goals, astonishing breakthroughs can be expected

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Paratek Pharmaceuticals Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Paratek Pharmaceuticals Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Paratek Pharmaceuticals Inc..